APOL1 channel blocker reduces proteinuria in FSGS

被引：0
|
作者：
Olabisi, Opeyemi A. [1 ,2 ]
机构：
[1] Duke Univ, Duke Mol Physiol Inst, Dept Med, Div Nephrol, Durham, NC USA
[2] Duke Univ, Duke Mol Physiol Inst, Dept Med, Div Nephrol, 300 N Duke St Off 50-104, Durham, NC 27701 USA
来源：
KIDNEY INTERNATIONAL | 2023年 / 104卷 / 02期
关键词：
chronic kidney disease; focal segmental glomerulosclerosis; nephrotic syndrome; KIDNEY-DISEASE; VARIANTS; MYH9;
D O I：
10.1016/j.kint.2023.04.022
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：228 / 230
页数：3
相关论文
共 50 条
  • [31] APOL1 Kidney Disease Risk Variants: An Evolving Landscape
    Dummer, Patrick D.
    Limou, Sophie
    Rosenberg, Avi Z.
    Heymann, Jurgen
    Nelson, George
    Winkler, Cheryl A.
    Kopp, Jeffrey B.
    SEMINARS IN NEPHROLOGY, 2015, 35 (03) : 222 - 236
  • [32] APOL1 Nephropathy Risk Alleles and Risk of Sepsis in Blacks
    Chaudhary, Ninad S.
    Moore, Justin X.
    Zakai, Neil A.
    Judd, Suzanne E.
    Naik, Rakhi P.
    Limou, Sophie
    Cushman, Mary
    Lange, Leslie A.
    Wang, Henry E.
    Winkler, Cheryl A.
    Irvin, Marguerite R.
    Kopp, Jeffrey B.
    Gutierrez, Orlando M.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (12): : 1733 - 1740
  • [33] Inhibiting APOL1 to Treat Kidney Disease
    Williams, Winfred W.
    Ingelfinger, Julie R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (11) : 1045 - 1049
  • [34] APOL1 Kidney Risk Variants and Proteomics
    Chen, Teresa K.
    Surapaneni, Aditya L.
    Arking, Dan E.
    Ballantyne, Christie M.
    Boerwinkle, Eric
    Chen, Jingsha
    Coresh, Josef
    Koettgen, Anna
    Susztak, Katalin
    Tin, Adrienne
    Yu, Bing
    Grams, Morgan E.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (05): : 684 - 692
  • [35] Evolution of the primate trypanolytic factor APOL1
    Thomson, Russell
    Genovese, Giulio
    Canon, Chelsea
    Kovacsics, Daniella
    Higgins, Matthew K.
    Carrington, Mark
    Winkler, Cheryl A.
    Kopp, Jeffrey
    Rotimi, Charles
    Adeyemo, Adebowale
    Doumatey, Ayo
    Ayodo, George
    Alper, Seth L.
    Pollak, Martin R.
    Friedman, David J.
    Raper, Jayne
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (20) : E2130 - E2139
  • [36] Clinical and Genetic Characteristics of CKD Patients with High-Risk APOL1 Genotypes
    Elliott, Mark D.
    Marasa, Maddalena
    Cocchi, Enrico
    Vena, Natalie
    Zhang, Jun Y.
    Khan, Atlas
    Murthy, Sarath Krishna
    Bheda, Shiraz
    Rasouly, Hila Milo
    Povysil, Gundula
    Kiryluk, Krzysztof
    Gharavi, Ali G.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 34 (05): : 909 - 919
  • [37] Balancing the genetic risk of APOL1 kidney disease variants
    Kabore, Nongodo Firmin
    Limou, Sophie
    NEPHROLOGIE & THERAPEUTIQUE, 2019, 15 : S79 - S84
  • [38] Stakeholder Perspectives on Returning Nonactionable Apolipoprotein L1 (APOL1) Genetic Results to African American Research Participants
    West, Kathleen M.
    Cavanaugh, Kerri L.
    Blacksher, Erika
    Fullerton, Stephanie M.
    Umeukeje, Ebele M.
    Young, Bessie
    Burke, Wylie
    JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2022, 17 (1-2) : 4 - 14
  • [39] APOL1 and Cardiovascular Disease A Story in Evolution
    Bajaj, Archna
    Susztak, Katalin
    Damrauer, Scott M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (09) : 1587 - 1589
  • [40] A Brief History of APOL1: A Gene Evolving
    Friedman, David J.
    SEMINARS IN NEPHROLOGY, 2017, 37 (06) : 508 - 513
12345